Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1498382 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $2.28 · Day +5.56% · Mkt cap $138M · 1Y −24.0% · Off 52W high −33.1% · Vol (1Y) 133.2% Price2024-10-18 → 2026-08-19 HURA close: $6.30 on 2024-10-18 to $2.28 on 2026-08-19. Split-adj closes · 240 of 449 · price returnⓘ At a glance | Short interest10.2% of sh out | | Days to cover31.9d | | 13F net flow (QoQ)+3.30% | | Top-10 13F concentration82.9% | | Next report (est.)2026-11-13 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$0 | | Earnings (TTM)-$30.6M | | ROE−169.2% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+201.3% | | 1Y−24.0% | | Since incept. (ann.)−42.5% |
Total return · from 2024-10-18ⓘ Risk | Ann. volatility (1Y)133.2% | | Ann. volatility (3Y)135.4% | | Sharpe (1Y)0.39 | | Sharpe (3Y)0.21 | | Max drawdown (1Y)−86.5% | | Max drawdown (3Y)−93.4% | | Beta (3Y vs SPY)−0.73 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| BlackRock, Inc. | 2.5M | $4M | 3.85% | +56.4% | | VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | $4M | 3.26% | new | | GEODE CAPITAL MANAGEMENT, LLC | 986,922 | $2M | 1.55% | +49.0% | | AQR CAPITAL MANAGEMENT LLC | 607,168 | $1M | 0.95% | +3580.3% | | STATE STREET CORP | 512,913 | $918,114 | 0.81% | +77.4% | | NORTHERN TRUST CORP | 298,187 | $533,754 | 0.47% | +55.6% | | VANGUARD FIDUCIARY TRUST CO | 287,133 | $513,968 | 0.45% | new | | VANGUARD PORTFOLIO MANAGEMENT LLC | 253,641 | $454,017 | 0.40% | new |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-14 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-14 | −$0.14 | — | — | — | | 2026-03-31 | 2026-05-15 | −$0.13 | — | $0 | — | | 2025-09-30 | 2025-11-14 | −$0.14 | — | — | — | | 2025-06-30 | 2025-08-14 | −$0.21 | — | — | — |
As-reported XBRL · next 2026-11-13 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
